Switch to:
Pain Therapeutics Inc (NAS:PTIE)
EV/EBITDA
-1.26 (As of Today)

EV/EBITDA ratio is calculated as enterprise value divided by its EBITDA. As of today, Pain Therapeutics Inc's enterprise value is $21.51 Mil. Pain Therapeutics Inc's earnings before depreciation and amortization for the trailing twelve months (TTM) ended in Jun. 2016 was $-17.04 Mil. Therefore, Pain Therapeutics Inc's EV/EBITDA ratio for today is -1.26.

PTIE' s EV/EBITDA Range Over the Past 10 Years
Min: -82.3   Max: 86.5
Current: -1.26

-82.3
86.5

During the past 13 years, the highest EV/EBITDA Ratio of Pain Therapeutics Inc was 86.50. The lowest was -82.30. And the median was 1.50.

PTIE's EV/EBITDA is ranked lower than
99.99% of the 257 Companies
in the Global Biotechnology industry.

( Industry Median: 19.37 vs. PTIE: -1.26 )

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

As of today, Pain Therapeutics Inc's stock price is $1.00. Pain Therapeutics Inc's earnings per share for the trailing twelve months (TTM) ended in Jun. 2016 was $-0.38. Therefore, Pain Therapeutics Inc's P/E Ratio for today is .

The "classic" EV/EBITDA ratio is much better in capturing debt and net cash than the P/E Ratio.


Definition

Pain Therapeutics Inc's EV/EBITDA for today is calculated as:

EV/EBITDA=Enterprise Value (Today)/Earnings Before Depreciation and Amortization (TTM)
=21.514/-17.038
=-1.26

Pain Therapeutics Inc's current Enterprise Value is $21.51 Mil.
Pain Therapeutics Inc's Earnings Before Depreciation and Amortization for the trailing twelve months (TTM) ended in Jun. 2016 was -3.672 (Sep. 2015 ) + -4.521 (Dec. 2015 ) + -5.815 (Mar. 2016 ) + -3.03 (Jun. 2016 ) = $-17.04 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Explanation

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

Pain Therapeutics Inc's P/E Ratio for today is calculated as:

P/E Ratio=Share Price (Today)/Earnings Per Share (TTM)
=1.00/-0.38
=

Pain Therapeutics Inc's share price for today is $1.00.
Pain Therapeutics Inc's Earnings Per Share for the trailing twelve months (TTM) ended in Jun. 2016 was -0.08 (Sep. 2015 ) + -0.1 (Dec. 2015 ) + -0.13 (Mar. 2016 ) + -0.07 (Jun. 2016 ) = $-0.38.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Study has found that the companies with the lowest EV/EBITDA outperforms companies measured as cheap by other ratios such as P/E Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Related Terms

Enterprise Value, Earnings Before Depreciation and Amortization, P/E Ratio


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Pain Therapeutics Inc Annual Data

Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13Dec14Dec15
ev2ebitda 5.0011.416.38-7.85-14.73-21.44-17.645.46-4.21-3.45

Pain Therapeutics Inc Quarterly Data

Mar14Jun14Sep14Dec14Mar15Jun15Sep15Dec15Mar16Jun16
ev2ebitda 7.198.596.00-4.21-4.09-3.59-4.14-3.45-4.25-4.49
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK